Avantor, Inc. (AVTR)
14.26
-0.20
(-1.38%)
USD |
NYSE |
Aug 24, 16:00
14.26
0.00 (0.00%)
After-Hours: 20:00
Avantor Enterprise Value : 13.04B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 13.04B |
| August 21, 2026 | 13.17B |
| August 20, 2026 | 13.03B |
| August 19, 2026 | 12.83B |
| August 18, 2026 | 12.41B |
| August 17, 2026 | 12.52B |
| August 14, 2026 | 12.63B |
| August 13, 2026 | 12.76B |
| August 12, 2026 | 12.81B |
| August 11, 2026 | 12.71B |
| August 10, 2026 | 12.68B |
| August 07, 2026 | 12.58B |
| August 06, 2026 | 12.31B |
| August 05, 2026 | 12.43B |
| August 04, 2026 | 12.65B |
| August 03, 2026 | 12.64B |
| July 31, 2026 | 12.71B |
| July 30, 2026 | 12.77B |
| July 29, 2026 | 13.12B |
| July 28, 2026 | 11.79B |
| July 27, 2026 | 11.35B |
| July 24, 2026 | 11.13B |
| July 23, 2026 | 11.07B |
| July 22, 2026 | 10.80B |
| July 21, 2026 | 10.83B |
| Date | Value |
|---|---|
| July 20, 2026 | 10.60B |
| July 17, 2026 | 10.88B |
| July 16, 2026 | 11.01B |
| July 15, 2026 | 10.97B |
| July 14, 2026 | 11.03B |
| July 13, 2026 | 10.53B |
| July 10, 2026 | 10.42B |
| July 09, 2026 | 10.50B |
| July 08, 2026 | 9.994B |
| July 07, 2026 | 10.29B |
| July 06, 2026 | 10.41B |
| July 02, 2026 | 10.37B |
| July 01, 2026 | 10.16B |
| June 30, 2026 | 10.09B |
| June 29, 2026 | 10.39B |
| June 26, 2026 | 10.56B |
| June 25, 2026 | 10.42B |
| June 24, 2026 | 10.15B |
| June 23, 2026 | 9.977B |
| June 22, 2026 | 9.922B |
| June 18, 2026 | 10.08B |
| June 17, 2026 | 9.997B |
| June 16, 2026 | 10.07B |
| June 15, 2026 | 10.17B |
| June 12, 2026 | 9.949B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medpace Holdings, Inc. | 16.90B |
| Champions Oncology, Inc. | 68.87M |
| Personalis, Inc. | 1.640B |
| Adaptive Biotechnologies Corp. | 4.138B |
| 10X Genomics, Inc. | 7.839B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 38.10M |
| Revenue (Quarterly) | 1.692B |
| Total Expenses (Quarterly) | 1.654B |
| EPS Diluted (Quarterly) | 0.0563 |
| Gross Profit Margin (Quarterly) | 31.73% |
| Profit Margin (Quarterly) | 2.25% |
| Earnings Yield | -5.94% |
| Operating Earnings Yield | 5.56% |
| Normalized Earnings Yield | 0.0589 |